Read the latest news from Saama.
Carlyle and co-investors including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund (“Merck GHI”), McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners
Private Equity Powerhouse Leads Group of Investors Bullish on AI Leading business publication Forbes broke the news of Saama’s $430 million funding deal with a
Thanks to the Global Pandemic, AI in Clinical Trials Is Here to Stay In this special feature for PharmaVOICE’s October 2021 Showcase on AI, Saama’s
CAMPBELL, Calif.–Saama Technologies, the #1 AI-powered clinical analytics company, will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10. Company
Saama’s customized cloud strategy aligned with AWS Saama Smart Applications for fast-tracked clinical innovation supported by AWS Saama ensures faster, safer clinical development via AWS
AI Is More than Just Business Process Efficiency In this forward-looking article, Saama’s Jonathan Burr, Senior VP, Clinical Platform Strategy, shows how AI is informing
An Interview with Suresh Katta Saama’s Founder and CEO, Suresh Katta, sat down with Outsourcing-Pharma for a fascinating interview about the digital transformation of the
Digital Transformation Included a Focus on Data Quality This article from Analytics Insight explains how Pfizer’s willingness to embrace digital transformation and artificial intelligence (AI)
Learning Lessons from Abbott’s Global Pandemic Defense Coalition In response to an article in Modern Healthcare on the Abbott Pandemic Defense Coalition, Nekzad Shroff, Saama’s
